GoodRx Gold (GDRX) - Multiplikator Forward P/S

Tandha merek goodrx.com (GDRX)

The current forward P/S ratio reflects market expectations for GoodRx Holdings, Inc. (GDRX). Investors value the high scalability of an IT model that incurs no logistics costs. Dominance is sustained through the control of pricing data and influence over pharmacy commissions. The environmental footprint remains minimal due to the digital nature of operations. The value of 0.20 represents the current metric, determining the extent to which business value is priced relative to future sales.

GDRX GoodRx: Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ing interval 04.07.2022 - 17.11.2026

GoodRx Holdings, Inc. - rincian analitis lan metrik utama (GDRX)

- rega saham lan target rega konsensus:
Analisis komprehensif perusahaan:GDRX (GoodRx Holdings, Inc.)
Sampel barang GoodRx Gold

GoodRx Holdings, Inc. (GDRX) possesses high scalability, yet margin stagnation driven by pharmacy algorithms limits its operating leverage. The expected price-to-sales ratio digitizes this trend, benchmarking current market capitalization against projected sales volume. This metric measures the extent of the market's overvaluation of future flows, revealing either investment attractiveness or the risk of a systemic slowdown in expansion. Analysis of this chart allows for the determination of the fair value point for a mature software business.

Analisis pesaing GoodRx Holdings, Inc.

Rasio rega marang prakiraan pendapatan Veeva Corp VEEV|Rasio rega marang pendapatan sing dikarepake DOCS (Doximity, Inc.)|HQY: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan WAY (waystar.com)|CorVel Corp. (CRVL) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Privia Health (PRVA)|Rasio rega marang prakiraan pendapatan Huron Corp|Kapitalisasi marang prakiraan pendapatan CERT (Certara Corp)|Rasio rega marang prakiraan pendapatan Omnicell (OMCL)|SDGR (Schrödinger) - Rega forward marang dodolan|Phreesia Inc - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan OMDA|Evolent - Multiplikator Forward P/S|Rega forward marang dodolan HSTM (HealthStream Corp)|DH (Definitive Healthcare Inc.) - Multiplikator forward rega marang pendapatan|Consensus Cloud Solutions (CCSI) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan agilon health|Kapitalisasi marang prakiraan pendapatan ABSI (Absci Corporation)|Multiplikator Forward P/S SY|NRC (National Research Corp) - Rega forward marang dodolan|Multiplikator Forward P/S SPOK (spok.com)|Rega forward marang dodolan OPRX|trubridge.com - Multiplikator Forward P/S|SLP (Simulations Plus) - Kapitalisasi marang prakiraan pendapatan|SOPHiA GENETICS SA (SOPH) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Health Catalyst, Inc.|Multiplikator forward rega marang pendapatan CCLD|researchsolutions.com (RSSS) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S DLHC|OneMedNet Corp - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S SCNX (Scienture Corp)|Rasio rega marang pendapatan sing dikarepake HCTI (Healthcare Triangle Corp)|iSpecimen Corp - Multiplikator Forward P/S|Rega forward marang dodolan BFRG (bullfrogai.com)|WORX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan MSP Recovery|Rasio rega marang prakiraan pendapatan icoreconnect.com|MEDS: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Orgenesis Inc. (ORGS)|Rasio kapitalisasi marang dodolan sing dikarepake R1 RCM, Inc.|Multiplikator Forward P/S SHCR (sharecare.com)|Rasio kapitalisasi marang dodolan sing dikarepake Streamline Health Solutions, Inc. (STRM)|SYRA - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Apollo Medical Holdings Inc. AMEH|Model N (MODN) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan NXGN